RCUS vs. STNE

In the year-to-date period, RCUS achieves a -40.03% return, which is significantly lower than STNE's 71.27% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Arcus Biosciences, Inc. (RCUS) and StoneCo Ltd. (STNE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current RCUS Sharpe Ratio is -0.65, which is lower than the STNE Sharpe Ratio of -0.04. The chart below compares the historical Sharpe Ratios of RCUS and STNE, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither RCUS nor STNE has paid dividends to shareholders.

The maximum RCUS drawdown since its inception was -85.83%, smaller than the maximum STNE drawdown of -92.31%. Use the drawdown chart below to compare losses from any high point for RCUS and STNE.

Arcus Biosciences, Inc. (RCUS) has a higher volatility of 17.93% compared to StoneCo Ltd. (STNE) at 11.09%. This indicates that RCUS's price experiences larger fluctuations and is considered to be riskier than STNE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Arcus Biosciences, Inc. and StoneCo Ltd.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.